Candel Therapeutics (CADL) Current Assets (2020 - 2025)
Candel Therapeutics (CADL) posted Current Assets of $121.4 million for Q4 2025, up 34.68% sequentially from $90.1 million in Q3 2025, and up 16.94% YoY from $103.8 million in Q4 2024.
Candel Therapeutics (CADL) Current Assets (2020 - 2025) Analysis & Trends
Candel Therapeutics has reported Current Assets for 6 years, with the latest figure at $121.4 million in Q4 2025.
- Quarterly Current Assets rose 16.94% year-over-year to $121.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $121.4 million (up 16.94% YoY) and the FY2025 annual result came in at $121.4 million, up 16.94% from the prior year.
- Current Assets climbed to $121.4 million in Q4 2025 per CADL's latest filing, from $90.1 million in the prior quarter.
- Over five years, Current Assets peaked at $121.4 million in Q4 2025 and troughed at $18.1 million in Q3 2024.
- A 5-year average of $69.0 million and a median of $79.1 million in 2022 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2025: Current Assets tumbled 59.9% in 2024, then surged 398.39% in 2025.
- Over 5 years, Current Assets stood at $84.9 million in 2021, then slipped by 15.3% to $71.9 million in 2022, then slumped by 48.85% to $36.8 million in 2023, then surged by 182.1% to $103.8 million in 2024, then climbed by 16.94% to $121.4 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $121.4 million, $90.1 million, and $103.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - | 121.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 121.39 Mn |
| Sep 30, 2025 | 90.13 Mn |
| Jun 30, 2025 | 103.61 Mn |
| Mar 31, 2025 | 93.15 Mn |
| Dec 31, 2024 | 103.80 Mn |
| Sep 30, 2024 | 18.09 Mn |
| Jun 30, 2024 | 22.74 Mn |
| Mar 31, 2024 | 27.14 Mn |
| Dec 31, 2023 | 36.80 Mn |
| Sep 30, 2023 | 45.10 Mn |
| Jun 30, 2023 | 53.36 Mn |
| Mar 31, 2023 | 61.88 Mn |
| Dec 31, 2022 | 71.95 Mn |
| Sep 30, 2022 | 79.07 Mn |
| Jun 30, 2022 | 87.33 Mn |
| Mar 31, 2022 | 95.65 Mn |
| Dec 31, 2021 | 84.95 Mn |
| Sep 30, 2021 | 90.95 Mn |
| Jun 30, 2021 | 24.43 Mn |
| Dec 31, 2020 | 35.15 Mn |